M Schaadt
Overview
Explore the profile of M Schaadt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
448
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bliddal H, Moller H, Schaadt M, Danneskiold-Samsoe B
J Rheumatol
. 2000 Nov;
27(11):2658-9.
PMID: 11093449
Objective: To investigate the levels of hyaluronic acid (HA) in Danish patients with fibromyalgia (FM). Methods: Serum levels of HA were determined in 53 patients with established FM and 55...
2.
Jucker M, Abts H, Li W, Schindler R, Merz H, Gunther A, et al.
Blood
. 1991 Jun;
77(11):2413-8.
PMID: 1710152
Interleukin-6 (IL-6) is a multipotent lymphokine that can mediate differentiation of B cells into Ig-secreting cells, stimulate the growth of plasmacytomas, hybridomas, and T cells, and induce acute-phase proteins in...
3.
Diehl V, von Kalle C, Fonatsch C, Tesch H, Juecker M, Schaadt M
Semin Oncol
. 1990 Dec;
17(6):660-72.
PMID: 2251513
No abstract available.
4.
Katay I, Wirnitzer U, Burrichter H, von Kalle C, Diehl V, Schaadt M
Blood
. 1990 Aug;
76(4):791-6.
PMID: 2383657
Diminished rosetting capacity of T cells is a well-known phenomenon in Hodgkin's disease, and inhibitors of E rosette formation have been reported to be present in the plasma of patients...
5.
Jucker M, Schaadt M, Diehl V, Poppema S, Jones D, Tesch H
Hematol Oncol
. 1990 Jul;
8(4):191-204.
PMID: 2210688
The expression of 20 proto-oncogenes was analysed by Northern blotting in four cell lines derived from patients with Hodgkin's disease (L428, L540, CO and DEV) and compared to lymphoid and...
6.
Peters K, Dommaschk J, Grundmann R, Schaadt M, Schicha H
Arzneimittelforschung
. 1990 Apr;
40(4):508-10.
PMID: 2357253
As neopterin is only secreted by stimulated macrophages, serum neopterin levels are an important marker for cellular immunity. Daily determinations of serum neopterin were performed in five patients with advanced...
7.
Schaadt M, Pfreundschuh M, Lorscheidt G, Peters K, Steinmetz T, Diehl V
J Biol Response Mod
. 1990 Apr;
9(2):247-50.
PMID: 2341863
Fifteen patients with colorectal carcinoma received a 30-min intravenous infusion of recombinant human tumor necrosis factor (rHuTNF) to investigate the value of rHuTNF in the treatment of colorectal carcinoma. Patients...
8.
Tepass T, Lorscheidt G, Pfreundschuh M, Schaadt M, Diehl V
Eur J Haematol
. 1989 Oct;
43(4):286-96.
PMID: 2555213
In in vitro experiments, tumor necrosis factor (rHuTNF alpha) was found to inhibit spontaneous and directed migration of normal human neutrophils and monocytes. RHuTNF alpha showed no chemoattractant activity. In...
9.
Pfreundschuh M, Genth B, Kirchner H, Scheurich P, Lindemann A, Steinmetz H, et al.
Onkologie
. 1989 Jun;
12(3):128-30.
PMID: 2548141
To find clues as to the possible mechanisms of resistance against the cytotoxic activity of tumor necrosis factor (TNF), we developed TNF-resistant and TNF-sensitive subclones of the human cervic carcinoma...
10.
Pfreundschuh M, Steinmetz H, Tuschen R, Schenk V, Diehl V, Schaadt M
Eur J Cancer Clin Oncol
. 1989 Feb;
25(2):379-88.
PMID: 2702990
No abstract available.